BMT, Gamida Cell Ltd, hematologic malignancies, Omidubicel
Omidubicel is approved by USFDA to reduce time to neutrophil recovery and infection in patients with hematologic malignancies
May 2023: Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) was approved by the Food and Drug Administration for use in adult and paediatric patients (12 years of age and older) with hematologic malignancies who are scheduled to recei..
Pembrolizumab, USFDA
Enfortumab vedotin-ejfv with pembrolizumab is approved by USFDA for locally advanced or metastatic urothelial carcinoma
Feb 2024: The Food and Drug Administration has sped up the approval process for two drugs, enfortumab vedotin-ejfv (Padcev, Astellas Pharma) and pembrolizumab (Keytruda, Merck). These drugs are meant to treat people with locally ..
Incyte Corporation, MCC, Merkel cell carcinoma, PODIUM-201, retifanlimab-dlwr, Zynyz
Retifanlimab-dlwr is approved by FDA for metastatic or recurrent locally advanced Merkel cell carcinoma
April 2023: Retifanlimab-dlwr (Zynyz, Incyte Corporation) received fast approval from the Food and Drug Administration to treat adult patients with metastatic or recurrent locally advanced Merkel cell cancer (MCC). In PODIUM-2..
TIL immunotherapy, TILs therapy, Tumor Infiltrating Lymphocytes
Tumor Infiltrating lymphocytes (TIL) Immunotherapy in India
April 2023: Using the body's immune system to fight cancer cells is the goal of the promising cancer treatment method known as tumour infiltrating lymphocytes (TIL) immunotherapy. The process entails taking immune cells called TI..
Abemaciclib, aromatase inhibitor, Eli Lilly and Company, endocrine therapy, Tamoxifen, Verzenio
Abemaciclib with endocrine therapy is approved by FDA in HER 2 positive breast cancer
March 2023: Abemaciclib (Verzenio, Eli Lilly and Company) and endocrine therapy (tamoxifen or an aromatase inhibitor) have been approved by the Food and Drug Administration (FDA) for the adjuvant treatment of adult patients with ..
Did I Ever Tell You This, Jurassic Park, Jurassic World Dominion, Sam Neill
Sam Neill, “Jurassic Park” actor, has been diagnosed with blood cancer
March 2023: The first chapter of Sam Neill's memoir would be a tremendous shock to someone who had no prior knowledge of it. It starts out funny enough: a great yarn about his daughter Elena being questioned about her father's jo..
Clinical trials
MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer
March 2023: Brief Summary: The purpose of this clinical trial is to find out if anti-MESO antigen receptor CAR T-cell therapy can be used to treat epithelial ovarian cancer that has come back or stopped responding to other..
CAR T Cell therapy trials, Glioblastoma, glioblastoma trials, gliomas
Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
March 2023: Study Type : Interventional (Clinical Trial)Estimated Enrollment : 30 participantsAllocation: N/AIntervention Model: Sequential AssignmentIntervention Model Description: a "3+3" design is used to determine Maximum..
CAR T Cell therapy trials, multiple myeloma trials
Clinical trial on CAR-T Cell therapy for patients with BCMA/TACI-positive relapsed and/or refractory multiple myeloma
Brief Summary: A study of APRIL CAR-T cells therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma Detailed Description: This is a single arm, open-label, si..
BALL, BALL Trials, CAR T Cell therapy trials, Clinical trials, Leukemia, Leukemia trials, Trials in China
Clinical trial recruitment for BALL CAR T-Cell therapy
16th March 2023: The treatment of cancer is being revolutionized by new immunotherapeutic drugs that target the microenvironment at the tumour site. T cells with chimeric antigen receptors (CAR) are being extensively researched ..